Journal of Hepatology
Volume 33, Issue 3 , Pages 423-429 , September 2000

Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis

  • Josep M Llovet

      Affiliations

    • BCLC (Barcelona-Clinic Liver Cancer) Group, Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain
    • ,
  • Eduardo Moitinho

      Affiliations

    • BCLC (Barcelona-Clinic Liver Cancer) Group, Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain
    • ,
  • Margarita Sala

      Affiliations

    • BCLC (Barcelona-Clinic Liver Cancer) Group, Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain
    • ,
  • Ramón Bataller

      Affiliations

    • BCLC (Barcelona-Clinic Liver Cancer) Group, Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain
    • ,
  • Pilar Rodríguez-Iglesias

      Affiliations

    • Gastroenterology Department, Hospital Germans Trias i Pujol, Badalona, Catalonia, Spain
    • ,
  • Antoni Castells

      Affiliations

    • BCLC (Barcelona-Clinic Liver Cancer) Group, Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain
    • ,
  • Javier Fernández

      Affiliations

    • BCLC (Barcelona-Clinic Liver Cancer) Group, Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain
    • ,
  • Ramon Planas

      Affiliations

    • Gastroenterology Department, Hospital Germans Trias i Pujol, Badalona, Catalonia, Spain
    • ,
  • Miquel Navasa

      Affiliations

    • Corresponding Author InformationMiquel Navasa, Liver Unit, Hospital Clínic, Villarroel, 170, 08036 Barcelona, Spain. Tel: 34 93 2275499. Fax: 34 93 451 52 72.
    • BCLC (Barcelona-Clinic Liver Cancer) Group, Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain
    • ,
  • Jordi Bruix

      Affiliations

    • BCLC (Barcelona-Clinic Liver Cancer) Group, Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain
    • ,
  • Juan Rodés

      Affiliations

    • BCLC (Barcelona-Clinic Liver Cancer) Group, Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain

Received 3 December 1999 ,Revised 31 January 2000 ,Accepted 12 February 2000.

References 

  1. Navasa M, Rimola A, Rodés J. Bacterial infections in liver disease. Semin Liver Dis. 1997;17:323–333
  2. Navasa M. Treatment and prophylaxis of spontaneous bacterial peritonitis. In:  Arroyo V,  Ginès P,  Rodés J,  Schrier R editor. Ascites and Renal Dysfunction in Liver Disease. Malden, Massachusetts: Blackwell Science; 1999;p. 538–549
  3. Garcia-Tsao G. Spontaneous bacterial peritonitis. Gastroenterol Clin North Am. 1992;21:257–275
  4. Felisart J, Rimola A, Arroyo V, Pérez-Ayuso RM, Quintero E, Ginès P, et al.  Cefotaxime is more effective than is ampicillintobramycin in cirrhotics with severe infections. Hepatology. 1985;5:457–462
  5. Navasa M, Follo A, Llovet JM, Clemente G, Vargas V, Rimola A, et al.  Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology. 1996;111:1011–1017
  6. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz del Arbol L, et al.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403–409
  7. Runyon BA, McHutchinson JG, Antillon MR, Akriviadis EA, Montano AA. Short-course versus long course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology. 1991;100:1737–1742
  8. Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, et al.  Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology. 1994;20:1495–1501
  9. Titó Ll, Rimola A, Ginés P, Llach J, Arroyo V, Rodés J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology. 1988;8:27–31
  10. Silvain C, Besson I, Ingrand P, Mannant PR, Fort E, Beauchant M. Prognosis and long-term recurrence of spontaneous bacterial peritonitis in cirrhosis. J Hepatol. 1993;19:188–189
  11. Consensus statement on indications for liver transplantation: Paris, June 22-23, 1993. Hepatology. 1994;20:63S–68S
  12. Toledo C, Salmerón JM, Rimola A, Navasa M, Arroyo V, Llach J, et al.  Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology. 1993;17:251–257
  13. Hoefs JC, Canawati HN, Sapico FJ, Hopkins RR, Weiner J, Montgomerie Z. Spontaneous bacterial peritonitis. Hepatology. 1982;2:399–407
  14. Weinstein MP, Ianninni PB, Stratton CW, Eickhoff TC. Spontaneous bacterial peritonitis: a review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med. 1978;64:592–598
  15. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997;112:463–472
  16. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al.  Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991;325:675–680
  17. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329–337
  18. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso MC, Sala M, et al.  Natural history of untreated nonsurgical hepatocellular carcinoma. Rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62–67
  19. Okuda K, Otshuki , Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al.  Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918–928
  20. Hoefs JC, Runyon BA. Spontaneous bacterial peritonitis. Dis Mon. 1985;31:1–48
  21. Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology. 1988;95:1351–1355
  22. Ginès P, Rimola A, Planas R, Vargas V, Marco F, Almela M, et al.  Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12:716–724
  23. Bruix J. Treatment of hepatocellular carcinoma. Hepatology. 1997;25:259–262
  24. Sorensen JB, Klee M, Palshof T, Hansen HH. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer. 1993;67:773–775
  25. Gómez-Jiménez J, Ribera E, Gasser I, Artaza MA, Del Valle O, Pahissa A, et al.  Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob Agents Chemother. 1993;37:1587–1592
  26. Rimola A, Salmerón JM, Clemente G, Rodrigo L, Obrador A, Miranda ML, et al.  Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology. 1995;21:674–679
  27. Arroyo V, Ginès P, Rimola A, Gaya J. Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. Am J Med. 1986;81:104–122
  28. Navasa M, Follo A, Filella X, Jiménez W, Francitorra A, Planas R, et al.  Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology. 1998;27:1227–1232
  29. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodés J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology. 1984;4:53–58
  30. Llach J, Terés J, García-Pagán JC, Calvet X, Saperas E, Rodés J. Hipertransaminasemia en el curso de una hemorragia digestiva alta por varices esofágicas en pacientes cirróticos. Su asociación con el carcinoma hepatocelular. Gastoenterol Hepatol. 1988;11:273–275
  31. Inadomi J, Sonnenberg A. Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis. Gastroenterology. 1997;113:1289–1294
  32. Llovet JM, Bruix J, Fuster J, Castells A, García-Valdecasas JC, Grande L, et al.  Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology. 1998;27:1572–1577
  33. Mazzaffero V, Regalia E, Doci R, Andreola S, Pulvirenti A. Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699

PII: S0168-8278(00)80278-0

Journal of Hepatology
Volume 33, Issue 3 , Pages 423-429 , September 2000

Article Tools

* Image Usage & Resolution